<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1713C1F9-B8C3-45BD-BECD-471370A8838F"><gtr:id>1713C1F9-B8C3-45BD-BECD-471370A8838F</gtr:id><gtr:name>Complutense University of Madrid</gtr:name><gtr:address><gtr:line1>Ciudad Universitaria</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/11F03DA0-8653-483C-A0BE-AE6BDC8024AA"><gtr:id>11F03DA0-8653-483C-A0BE-AE6BDC8024AA</gtr:id><gtr:name>University of Tsukuba</gtr:name><gtr:address><gtr:line1>University of Tsukuba</gtr:line1><gtr:line2>1-1-1 Tennodai</gtr:line2><gtr:line4>Tsukuba</gtr:line4><gtr:line5>Ibaraki-ken</gtr:line5><gtr:postCode>305</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B3A39331-13C5-4AB9-89C8-98B6E4230BF5"><gtr:id>B3A39331-13C5-4AB9-89C8-98B6E4230BF5</gtr:id><gtr:name>Beat-PCD</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C80FA399-9F25-4473-8481-C60F0F3D5D18"><gtr:id>C80FA399-9F25-4473-8481-C60F0F3D5D18</gtr:id><gtr:name>Cancer Research UK Cambridge Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/56ABF1BE-A3FA-4CB5-A6E5-DF21BD84ADAD"><gtr:id>56ABF1BE-A3FA-4CB5-A6E5-DF21BD84ADAD</gtr:id><gtr:name>UK Cystic Fibrosis Gene Therapy Consortium</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB"><gtr:id>FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB</gtr:id><gtr:name>University College Dublin</gtr:name><gtr:address><gtr:line1>Belfield</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Ireland</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1713C1F9-B8C3-45BD-BECD-471370A8838F"><gtr:id>1713C1F9-B8C3-45BD-BECD-471370A8838F</gtr:id><gtr:name>Complutense University of Madrid</gtr:name><gtr:address><gtr:line1>Ciudad Universitaria</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/11F03DA0-8653-483C-A0BE-AE6BDC8024AA"><gtr:id>11F03DA0-8653-483C-A0BE-AE6BDC8024AA</gtr:id><gtr:name>University of Tsukuba</gtr:name><gtr:address><gtr:line1>University of Tsukuba</gtr:line1><gtr:line2>1-1-1 Tennodai</gtr:line2><gtr:line4>Tsukuba</gtr:line4><gtr:line5>Ibaraki-ken</gtr:line5><gtr:postCode>305</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B3A39331-13C5-4AB9-89C8-98B6E4230BF5"><gtr:id>B3A39331-13C5-4AB9-89C8-98B6E4230BF5</gtr:id><gtr:name>Beat-PCD</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C80FA399-9F25-4473-8481-C60F0F3D5D18"><gtr:id>C80FA399-9F25-4473-8481-C60F0F3D5D18</gtr:id><gtr:name>Cancer Research UK Cambridge Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/56ABF1BE-A3FA-4CB5-A6E5-DF21BD84ADAD"><gtr:id>56ABF1BE-A3FA-4CB5-A6E5-DF21BD84ADAD</gtr:id><gtr:name>UK Cystic Fibrosis Gene Therapy Consortium</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB"><gtr:id>FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB</gtr:id><gtr:name>University College Dublin</gtr:name><gtr:address><gtr:line1>Belfield</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Ireland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/06F3DAF2-65F4-4FA2-A998-89EFB048E5A7"><gtr:id>06F3DAF2-65F4-4FA2-A998-89EFB048E5A7</gtr:id><gtr:firstName>Pleasantine</gtr:firstName><gtr:surname>Mill</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12018%2F26"><gtr:id>38109B95-BDA2-4F91-84BC-F8FE79F3612A</gtr:id><gtr:title>Molecular Genetics of Mammalian Cilia in Development and Disease</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12018/26</gtr:grantReference><gtr:abstractText>Patterning of the embryo is a tightly controlled process which requires the correct integration and interpretation of key developmental signals. A cell makes a decision of whether to differentiate, divide or migrate in response to these environmental cues. Small microtubule-based projections, or cilia, found on almost every mammalian cell play a critical role in signal transduction during development and disease. This is because cilia have a unique composition that is enriched in many receptors and signalling components, analogous to an antenna for focusing signalling responses. Dysfunction of the cilium underlies a group of human genetic disorders, termed ciliopathies. The inability to maintain a cilium results in a spectrum of health problems ranging from skeletal defects and cystic kidney disease, to cognitive and behavioural defects, as well as obesity. Despite a growing list of genes implicated in cilia biology, we have very little idea what the encoded proteins actually do in cells, or how mutations cause the disease. Consequently most of these cilia-related diseases are currently untreatable. Using mouse as a genetic model of human disease, we aim to understand how cilia are maintained as a specialized signalling compartments. We are also searching for cell-type specific differences how traffic to the cilia, necessary for environmental sensing, is regulated. Identifying novel ciliary components and determining their functions will lead to a better understanding for the diagnosis and clinical management within ciliopathy spectrum.</gtr:abstractText><gtr:technicalSummary>Cilia are small, microtubule-based projections from the surface of most mammalian cells. Cilia regulate the responsiveness of the cell to key developmental signals, including Hedgehog (Hh) and Wnts. Cilia are distinct sub-compartments of the cell with unique membrane and cytosolic compositions, enriched in many receptors and signalling components. While recent studies have shown that mutations in genes required for cilia structure in both mice and humans result in a broad spectrum of developmental disorders, termed ciliopathies, little is known about how this compartmentalization of the cilia itself is maintained. 

The aim of our work is to investigate the genetic and molecular mechanisms regulating mammalian cilia compartmentalization necessary for development and tissue homeostasis. Using a combination of mouse models and primary cell culture, we hope to identify novel mechanisms of regulating traffic into the ciliary compartment. These studies will lead to a better understanding for the diagnosis and clinical management within ciliopathy spectrum.
The objectives for this project are:
1) To investigate sorting mechanisms regulating traffic into the ciliary compartment. 
2) To determine cell-specific physiological consequences of loss of ciliary trafficking.
3) To identify post-translational modifications which ?tag? cargo for dynamic and specific trafficking into and out of the cilia.

Our overall aim is to generate new mouse models of human disease candidates, to correlate genotype, cellular phenotype, and overall health. We examine the effects of these mutations integrating microscopy, transcriptomics and proteomics. Taken together, we hope this work will help us evaluate how a genetic mutation leads to specific cellular and physiological consequences that will help to develop evidence-based strategies for clinical management of ciliopathies.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2014-02-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1050000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:department>Systems Biology Ireland</gtr:department><gtr:description>Defining Interaction Networks of Human Ciliopathy Proteins</gtr:description><gtr:id>5EC12391-36F2-42FD-A3E5-0EA0B23A92AF</gtr:id><gtr:impact>Publications:
Diggle CP, Moore DJ, Mali G, zur Lage P, Ait-Lounis A, Schmidts M, Shoemark A, Garcia Munoz A, Halachev MR, Gautier P, Yeyati PL, Bonthron DT, Carr IM, Hayward B, Markham AF, Hope JE, von Kriegsheim A, Mitchison HM, Jackson IJ, Durand B, Reith W, Sheridan E, Jarman AP, Mill P. HEATR2 plays a conserved role in assembly of the ciliary motile apparatus.PLoS Genet. 2014 Sep 18;10(9):e1004577. doi: 10.1371/journal.pgen.1004577. eCollection 2014 Sep.

Yeyati, PL, Schiller, R, Mali, G, Kasioulis, I, Kawamura, A, Adams, IR, Playfoot, C, Gilbert, N, Heyningen, VH, Wills, JH, Kriegsheim, AV, Finch, A, Sakai, J, Schofield, CJ, Jackson, IJ, Mill, P. KDM3A coordinates actin dynamics with intraflagellar transport to regulate cilia stability. J Cell Biol Feb 2017, jcb.201607032; DOI: 10.1083/jcb.201607032

Hall, EA, Nahorski, MS, Murray, LM, Shaheen, R, Perkins, E, Dissanayake, KN, Kristaryanto, Y, Jones, RA, Vogt, J, Rivagorda, M, Handley, MT, Mali, GR, Quidwai, T, Soares, DC, Keighren, MA, McKie, L, Mort, RL, Gammoh, N, Garcia-Munoz, A, Davey, T, Vermeren, M, Walsh, D, Budd, R, Aligianis, IA, Faqei, E, Quigley, AJ, Jackson, IJ, Kulathu, Y, Jackson, M, Ribchester, R, Kriegsheim, AV, Alkuraya, FS, Woods, CG, Maher, ER, Mill, P. Mutations in PLAA cause a lethal infantile epileptic encephalopathy by disrupting ubiquitin-mediated endolysosomal degradation of synaptic proteins. American Journal of Human Genetics (revised version submitted).</gtr:impact><gtr:outcomeId>5447a58c5f8da8.15295904-1</gtr:outcomeId><gtr:partnerContribution>Preparation and analysis of mass spec proteomics.</gtr:partnerContribution><gtr:piContribution>Provision of affinity captured samples for label-free proteomics analysis in human and fly samples. Validation of potential hits by IP-WB, IF and PLA. Characterization of interaction networks in null cells/animals.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Beat-PCD</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>COST Action BEAT-PCD</gtr:description><gtr:id>24FFF708-98A2-4BDD-B479-5130BF44CBC9</gtr:id><gtr:impact>Funding for meetings, workshops and travel.

I presented a podium talk at the Gordon Research Conference (February 2017, Galveston Texas) Cilia, Mucus and Mucociliary Interactions meeting.</gtr:impact><gtr:outcomeId>56deedfa47ad47.62781225-1</gtr:outcomeId><gtr:partnerContribution>COST Actions provide funds for cooperation, collaboration and the development of ideas through meetings, workshops, and short term lab visits. It aims to help seek more direct forms of funding down the way.</gtr:partnerContribution><gtr:piContribution>As member of this European-based consortium, we are part of the Basic Science work group, that is intended to encourage communication between basic and clinical scientists working on cilia and PCD. In particular, we will be providing models of PCD (animal and cellular) with the aim of developing them to evaluate pre-clinical studies for novel therapies for PCD.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK Cambridge Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Role of Centriolar Satellites in Mammalian Development</gtr:description><gtr:id>AA3AA241-5232-492B-9893-7F4DBFCC7D63</gtr:id><gtr:impact>This collaboration is in its early stages, we have generated the mice but no further outcomes yet.</gtr:impact><gtr:outcomeId>58c9bd077a7c79.93583327-1</gtr:outcomeId><gtr:partnerContribution>Fanni Gegely has a unique set of PCM1 interacting proteins, many of which are novel and are potential human disease genes for ciliopathies.</gtr:partnerContribution><gtr:piContribution>In collaboration with Fanni Gegely, we have generated null alleles as well as SNAP-tagged alleles of the key centriolar satellite gene PCM-1 in mouse by CRISPR gene editing. If PCM1 is essential for centriolar satellites in vivo as it is in vitro, we would expect mutant embryos to be embryonic lethal, with profound defects in ciliogenesis, centriole duplication and DNA damage response. Key human disease genes implicated in centrosomes, cilia and DNA repair dynamically localize to centriolar satelittes where it is proposed these structures play key roles is regulating access between cellular compartments. We will test this during embryogenesis as well as adult homeostasis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>UK Cystic Fibrosis Gene Therapy Consortium</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UK GTC</gtr:description><gtr:id>A8C6A90A-8783-4A6B-A957-F112641D2DBB</gtr:id><gtr:impact>We were funded for a MRC Confidence in Concept grant for therapeutic gene editing for PCD. We will be applying for the next tranche of translational funding in late 2016 to continue this work in partnership with UK CF GTC.

The UK CF GTC has a Wellcome Portfolio application which is awaiting a decision regarding repurposing of their reagents for other pulmonary genetic diseases: in collaboration with Dr. Chris Boyd (Centre for Genomics and Experimental Medicine, University of Edinburgh) we will lead the PCD arm of the program.</gtr:impact><gtr:outcomeId>56dec8885c3aa9.31694581-1</gtr:outcomeId><gtr:partnerContribution>The UK CF GTC has provided access to their non-viral (GL67) as well as viral vectors for repurposing for therapeutic gene editing to airways for PCD. More direct clinical links to the PCD unit at the Brompton will also be established to speed gene discovery, functional analysis and potential therapeutic developments.</gtr:partnerContribution><gtr:piContribution>My lab is the named collaborator on a Wellcome Portfolio application &amp;quot;Respiratory Gene Therapy Portfolio (RGTP)&amp;quot; that is in the final stages of review with the Wellcome Trust. We will provide expertise, reagents, mouse models and primary cell culture systems of PCD disease genes for the repurposing of non-viral and viral delivery methods for gene replacement therapy studies.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Center for Intergative Physiology</gtr:department><gtr:description>Functional Conservation in Ciliary Trafficking</gtr:description><gtr:id>A79D6838-EA28-4853-BE1A-BB01CC74E6AD</gtr:id><gtr:impact>PAPERS:

Hall,E.A., Keighren, M., Ford, M., Davey, T., Jarman, A.P., Smith, L.B.S, Jackson I.J. and Mill, P. (2013). Acute Versus Chronic Loss of Mammalian Azi1/Cep131 Results in Distinct Ciliary Phenotypes. PLoS Genetics. 9(12): e1003928. doi:10.1371/journal.pgen.1003928.
Diggle CP, Moore DJ, Mali G, zur Lage P, Ait-Lounis A, Schmidts M, Shoemark A, Garcia Munoz A, Halachev MR, Gautier P, Yeyati PL, Bonthron DT, Carr IM, Hayward B, Markham AF, Hope JE, von Kriegsheim A, Mitchison HM, Jackson IJ, Durand B, Reith W, Sheridan E, Jarman AP, Mill P.
HEATR2 plays a conserved role in assembly of the ciliary motile apparatus. PLoS Genet. 2014 Sep 18;10(9):e1004577. doi: 10.1371/journal.pgen.1004577. eCollection 2014 Sep.

PhD candidate: Girish Mail</gtr:impact><gtr:outcomeId>5447a0eb541248.76378038-1</gtr:outcomeId><gtr:partnerContribution>Identification and characterization of putative ciliary candidate genes in Drosophila cilia.</gtr:partnerContribution><gtr:piContribution>Characterization of function of ciliary candidate genes in mammalian cell culture and mouse mutant models.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Tsukuba</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:department>Department of Anatomy and Embryology</gtr:department><gtr:description>Genome editing of HEATR2 with CRISPR technology</gtr:description><gtr:id>9D8CE06A-BF82-40D3-95AF-0FCEA85CBE88</gtr:id><gtr:impact>I was invited to a talk in Tsukuba Global Science Week 2014. My student was also invited to give a talk where he won a &amp;quot;Young Scientist Award&amp;quot;.</gtr:impact><gtr:outcomeId>5447a26a69fa17.19303988-1</gtr:outcomeId><gtr:partnerContribution>Construction and testing of plasmids for injections.</gtr:partnerContribution><gtr:piContribution>Generation and characterization of CRISPR edited mouse mutant alleles.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Complutense University of Madrid</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Grupo de Gen??tica Humana y Patolog??a Molecular, Instituto de Investigaciones Biom??dicas</gtr:department><gtr:description>Functional Characterization of Candidates in Human Skeletal Dysplasias</gtr:description><gtr:id>8E247DDE-11F9-4FB3-B185-3563FF9B2C36</gtr:id><gtr:impact>A manuscript on the role of WDR35 in EVC is in preparation for submission the end of this year.
Mouse models of putative ciliopathy by CRISPR are being generated.</gtr:impact><gtr:outcomeId>5447a3ba124685.35660779-1</gtr:outcomeId><gtr:partnerContribution>Identification of novel skeletal dysplasia candidates.</gtr:partnerContribution><gtr:piContribution>Functional characterization of skeletal dysplasia candidates in mammalian cell and mouse models.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>18814</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Starter Grant: Molecular mechanisms of RPGR in photoreceptor degeneration in mouse models of Retinitis Pigmentosa, Awardee: Roly Megaw (Mill Lab)</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>Fight for Sight</gtr:fundingOrg><gtr:id>B224D371-A3DE-444A-B23F-0FCDDE11492B</gtr:id><gtr:outcomeId>58ca5f54479018.70805365</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35892</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Institutional Strategic Support Fund</gtr:department><gtr:description>Institutional Strategic Support Fund (ISSF2): In vivo correction of human retinitis pigmentosa mutations in mouse model</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>University of Edinburgh</gtr:fundingOrg><gtr:id>F01CAF7E-F827-404D-B93B-A31A78B904DD</gtr:id><gtr:outcomeId>58ca5dc7c454c8.74745735</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>29923</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Starter Grant for Clinical Lecturers: In vivo correction of a human mutation in a mouse model of retinitis pigmentosa. Awardee: Roly Megaw, Mill lab</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:id>0E83E3EB-55A9-4394-89C7-231CDBA4E2AF</gtr:id><gtr:outcomeId>58ca5fbf624242.44450383</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>27482</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Institutional Strategic Support Fund</gtr:department><gtr:description>Institutional Strategic Support Award 2 (ISSF2): Development of small molecule HDR agonists for In Vivo Therapeutic Gene Editing</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>University of Edinburgh</gtr:fundingOrg><gtr:id>35DD6FCD-C3B7-4947-B45D-D2D01A58EDBF</gtr:id><gtr:outcomeId>58ca5d094f30b9.67250601</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9344</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>BBSRC Impact Award</gtr:department><gtr:description>BBSRC Project Grant</gtr:description><gtr:end>2019-11-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/P00122X/1</gtr:fundingRef><gtr:id>58EAF154-6A2F-4AC6-B782-6ABA3AE47CFF</gtr:id><gtr:outcomeId>58c9c55a791320.37908217</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>49882</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Carnegie Collaborative Research Grant</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Carnegie Trust</gtr:fundingOrg><gtr:fundingRef>035424/1</gtr:fundingRef><gtr:id>4D73896F-95ED-47F6-8319-FFFD376D29D5</gtr:id><gtr:outcomeId>56a8ef1b80c040.07644511</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>124791</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Confidence in Concept</gtr:description><gtr:end>2015-07-02</gtr:end><gtr:fundingOrg>University of Edinburgh</gtr:fundingOrg><gtr:fundingRef>MRC/CIC3/021</gtr:fundingRef><gtr:id>C7CE667A-C17F-4A23-AB05-DDE823798D6D</gtr:id><gtr:outcomeId>56a8f04729a6e4.14630291</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have generated several mouse models of PCD disease genes with a range of human disease-like mutations (indels, duplications, insertions and inversions) which we will use for testing therapeutic benefit of somatic gene editing. In parallel, these models will also be used in collaboration with the UK CF Gene Therapy Consortium looking at repurposing reagents for gene replacement therapies for PCD. These animals are excellent models of human PCD disease, from pathology to molecular mechanism.</gtr:description><gtr:id>14EE9AC4-5547-4C2D-BA51-E72927562E6F</gtr:id><gtr:impact>Carnegie Collaborative Research Grant</gtr:impact><gtr:outcomeId>56decb53ce6444.06137472</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>PCD Mouse models</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have generated a mouse model for rapid and scaleable monitoring gene editing events in situ, allowing tracking of potentially damaging non-homologous end-joining (NHEJ) versus therapeutically desirable homology-driven repair (HDR) events in a whole organism, tissue or field of primary cells. This model will be essential for optimizing gene editing reagents and vehicles to establish robust protocol for therapeutic gene editing in target tissues of interest.</gtr:description><gtr:id>1300DCF8-5BF5-4DF5-9593-CBA5C94797D5</gtr:id><gtr:impact>MRC Confidence in Concept award.</gtr:impact><gtr:outcomeId>56decb1d280543.56701789</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>In vivo gene editing reporter</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>22902692-0640-460D-AE0B-073600502337</gtr:id><gtr:title>Gelsolin dysfunction causes photoreceptor loss in induced pluripotent cell and animal retinitis pigmentosa models.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9710d3f1bbceff3076101bfa10b46d2"><gtr:id>d9710d3f1bbceff3076101bfa10b46d2</gtr:id><gtr:otherNames>Megaw R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a3285277c71b3.36468689</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76FBB66D-B2FE-438A-832A-77B61168B1CD</gtr:id><gtr:title>PLAA Mutations Cause a Lethal Infantile Epileptic Encephalopathy by Disrupting Ubiquitin-Mediated Endolysosomal Degradation of Synaptic Proteins.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f08913e7a930a8f2ea372c20e9ee9e4e"><gtr:id>f08913e7a930a8f2ea372c20e9ee9e4e</gtr:id><gtr:otherNames>Hall EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5a32822a2b2f57.48487425</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4A3CEB4-BC96-4AF8-8D2F-3296BADC32CF</gtr:id><gtr:title>KDM3A coordinates actin dynamics with intraflagellar transport to regulate cilia stability.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a383f379113d6d143695e9d71935937"><gtr:id>9a383f379113d6d143695e9d71935937</gtr:id><gtr:otherNames>Yeyati PL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>58c9ba2ac16fb2.51092740</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB6EE747-59AF-40FE-A651-C31F1C6A5922</gtr:id><gtr:title>Acute versus chronic loss of mammalian Azi1/Cep131 results in distinct ciliary phenotypes.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f08913e7a930a8f2ea372c20e9ee9e4e"><gtr:id>f08913e7a930a8f2ea372c20e9ee9e4e</gtr:id><gtr:otherNames>Hall EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>544796a65857a5.68487174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3DB5A81-0880-4337-950F-0ED20FD585E5</gtr:id><gtr:title>TALPID3 controls centrosome and cell polarity and the human ortholog KIAA0586 is mutated in Joubert syndrome (JBTS23).</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4d42c79d976fc7a780ab4ec8339f0d2"><gtr:id>d4d42c79d976fc7a780ab4ec8339f0d2</gtr:id><gtr:otherNames>Stephen LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>56a78b6eba5ba7.68738596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B758459-3C48-46E7-89EF-3D50348A41DB</gtr:id><gtr:title>HEATR2 plays a conserved role in assembly of the ciliary motile apparatus.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c2b657386a4a4105e8345c404cba4b3"><gtr:id>2c2b657386a4a4105e8345c404cba4b3</gtr:id><gtr:otherNames>Diggle CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>54479674b21bb7.69203425</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05303694-3C3B-4406-B10C-40A5D92A5233</gtr:id><gtr:title>Specific variants in WDR35 cause a distinctive form of Ellis-van Creveld syndrome by disrupting the recruitment of the EvC complex and SMO into the cilium.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00950bd9d51185a86bff5d5b7ac5b61c"><gtr:id>00950bd9d51185a86bff5d5b7ac5b61c</gtr:id><gtr:otherNames>Caparr?s-Mart?n JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>56a78afed9da89.59090077</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12018/26</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>